Drug Researchers Test 62 New Breast Cancer Drugs

DECEMBER 01, 2005
Ken Rankin

Pharmaceutical industry researchers are working on a total of 62 new medicines to treat breast cancer—a development that industry leaders say should give fresh hope to the millions of women at risk for the disease in the United States. The promising new breast cancer treatments are among more than 400 new medicines under development to treat diseases that affect American women, according to the results of a study conducted by the Pharmaceutical Research and Manufacturers of America (PhRMA).

In addition to the breast cancer treatments in the research and development pipeline, the PhRMA survey identified 72 pharmaceuticals in development for arthritis and musculoskeletal disorders; 58 for obstetric/gynecologic conditions; 62 for diabetes; and 47 for autoimmune diseases—all conditions that disproportionately afflict women. "It is heartening to know that there are so many medicines being developed to treat women—our grandmothers, mothers, wives, sisters, and daughters," said Billy Tauzin, president and chief executive officer of PhRMA.

Mr. Rankin is a freelance medical writer.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.